Celecoxib (Celebrex) Pediatric Dosing
ورودیهای بالینی بیمار
حداقل ۲ — حداکثر ۱۵۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- calculated≥ 0
The Celecoxib (Celebrex) Pediatric Dosing calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include weight kg. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Weight-band celecoxib dosing for juvenile rheumatoid arthritis (oral).
Clinical Indication
The Celecoxib (Celebrex) Pediatric Dosing is indicated for bedside clinical practice to support Weight-band celecoxib dosing for juvenile rheumatoid arthritis (oral).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
weight 10-25 kg -> 50 mg BID; weight >25 kg -> 100 mg BID
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| weight_kg | float | Yes | Child's weight in kilograms(kg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 0 | calculated | Weight-based dose |
Evidence-Based References (EBM)
- FDA Prescribing Information: Celebrex (celecoxib).